-- Christopher A. Kroeger, Director, Chief Executive Officer, on May 04, 2026, sold 49,744 shares in Maplight Therapeutics (MPLT) for $1,412,236. Following the Form 4 filing with the SEC, Kroeger has control over a total of 1,682,010 voting common shares of the company, with 1,580,820 shares held directly and 101,190 controlled indirectly.
SEC Filing: